Progress of clinical research on new anti-breast cancer drugs independently developed in China
ZHANG Mengqi
XU Binghe
Abstract：Systemic therapy is one of the important means for breast cancer treatment. In recent years,China has made great progress in the research and development on new anti-breast cancer drugs,which include anti-HER2 therapy,chemotherapy,endocrine therapy and immunotherapy drugs that covers various molecular subtypes of breast cancer,and many of these clinical studies have changed the clinical practice of breast cancer treatment.Therefore,this article summarizes the clinical researches on new anti-breast cancer drugs independently developed in China in recent years,aiming to provide insights for clinical application and future research.
Keywords：Breast carcinomaChinese-developed drugsClinical researchTargeted therapyEndocrine therapy
Publication Date：2024-04-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 105-109 )